Physician profile

David B Drury

Family Medicine · Pelham, GA

NPI 1124093380

$7,988.51

in general payments reported to CMS, 2019-2025

33 companies · $668 in 2025

The $668 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,645.24

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $1,235.48 2019-2025 Trelegy Ellipta
Novo Nordisk INC $1,055.36 2019-2025 Ozempic, Rybelsus, Wegovy
Boehringer Ingelheim Pharmaceuticals, INC. $995.07 2019-2025 Jardiance, Ofev
Astrazeneca Pharmaceuticals LP $816.49 2019-2025 Airsupra, Farxiga, Breztri
Lilly USA, LLC $643.87 2019-2025 Mounjaro, Zepbound, Trulicity
Bayer Healthcare Pharmaceuticals INC. $387.96 2022-2025
Amgen INC. $377.08 2019-2025 Otezla, Repatha, Evenity
Dexcom, INC. $316.79 2021-2025 Dexcom G6 Transmitter
Janssen Pharmaceuticals, INC $315.01 2019-2022
Merck Sharp & Dohme LLC $301.15 2019-2023 Verquvo, Belsomra, Steglatro
Abbvie INC. $286.77 2021-2023 Vraylar
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $258.19 2019-2024 Xifaxan
Pfizer INC. $257.15 2019-2024
Allergan, INC. $129.41 2019-2021
Novartis Pharmaceuticals Corporation $109.12 2019-2023
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Kowa Pharmaceuticals America, INC. $80.91 2021-2025 Zoryve
Sanofi-Aventis U.S. LLC $56.43 2019
Sunovion Pharmaceuticals INC. $52.70 2019
Ultragenyx Pharmaceutical INC. $36.07 2021
Organogenesis INC. $32.92 2025 Affinity
Astellas Pharma US INC $32.78 2021-2024 Veozah
Amarin Pharma, INC. $29.92 2019
Ferring Pharmaceuticals INC. $21.40 2024 Euflexxa
Exact Sciences Corporation $20.74 2024 Cologuard Collection Kit
Biohaven Pharmaceutical Holding Company LTD. $18.57 2022
Almatica Pharma LLC $18.45 2021
Corium, LLC $17.69 2023 Adlarity
Kvk-Tech, INC. $17.67 2019
Ironwood Pharmaceuticals, INC $16.30 2021
Idorsia Pharmaceuticals US INC $15.03 2023 Quviviq
Avion Pharmaceuticals $14.87 2020
Otsuka America Pharmaceutical, INC. $14.31 2025 Rexulti
Phathom Pharmaceuticals, INC. $6.85 2025 Voquezna

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David B Drury

$7,988.51

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $668 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).

https://glasscript.com/doctor/96657/david-b-drury

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.